Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Wednesday, March 29, 2023.
Eucrates Biomedical Acquisition Corp. - Ordinary Shares (NASDAQ:EUCR)
Bull Market Weakness (+75) - EUCR is showing signs of short-term weakness, but still remains in the confines of a long-term uptrend. Keep an eye on EUCR as it may be in the beginning stages of a reversal.
Is it time to buy, sell, or avoid EUCR?
MarketClub looks at technical strength and momentum to determine if the timing is right for EUCR.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for EUCR
The long-term trend has been UP since Feb 15th, 2023 at 10.04
The intermediate-term trend has been UP since Dec 14th, 2022 at 9.96
The short-term trend has been UP since Feb 27th, 2023 at 10.09
Smart Scan Analysis for EUCR
Based on our trend formula, EUCR is rated as a +70 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 10.15 | 10.15 | 10.15 | 10.15 | 0.00 |
| Prev. Close | Volume | Bid | Ask | Time |
| 10.25 | 1906 | 2023-03-24 15:59:55 |
| 52wk High | 10.25 | 52wk High Date | 2023-03-28 |
| 52wk Low | 9.83 | 52wk Low Date | 2022-03-29 |
| Average Volume | 442 | Shares Outstanding | 4,206 |
| Assets | 105,516,334M | Liabilities | 3,931,730M |
| P/E Ratio | 56.9444 |